facebook twitter instagram linkedin google youtube vimeo tumblr yelp rss email podcast phone blog search brokercheck brokercheck Play Pause

Medical and Economic Trends Point to More Improvement Ahead

Presented by Tim Weller

Things continued to improve in May, with declines in new cases, deaths, positive test rates, and all other metrics. In fact, the month closed with conditions at their best since last summer. We did see some slowdowns in vaccination rate, but a substantial part of the population has been vaccinated—enough to have controlled the virus. Right now, the medical risks are low and are likely to decline further in the month ahead.

The economic news is more mixed. While the economy continues to normalize and grow, job growth in April was reported to have dropped off sharply, which raised concerns about the sustainability of that growth. While this was likely a blip, as other data such as layoffs continued to get better, it did raise concerns. Similarly, while business confidence remained high, it pulled back a bit. Although manufacturing continues to be strong, supply chain issues are starting to bite. Growth continues, but there are signs it may be slowing.

Nevertheless, for both medical and economic risks, we remain at perhaps the most positive point since the start of the pandemic, and the trends are for even more improvement. Markets are clearly on board with the news, as they remain close to all-time highs. Plus, with corporate earnings blowing away expectations, there may well be more upside ahead. Let’s take a look at the details.

The Virus: Case Growth Back to Levels of Last Summer

New cases per day. The most obvious metric for tracking the virus is daily new cases. Case growth has continued its steady decline in the past month. At this point, another infection wave looks unlikely, and the risks are dropping by the day.

New daily infection rates were 24,393 on May 27, down from 59,564 four weeks earlier, a decline of almost 60 percent. The seven-day average number of new cases per day was 23,060, down from 54,981 four weeks ago, a decline of almost 60 percent. Case growth is now at levels we saw last summer and is still going down. If this continues, we could be at pandemic-low case growth rates in a matter of weeks.

Source: https://www.worldometers.info/coronavirus/country/us/

Hospitalizations. We also see an improvement with hospitalizations. On May 22, there were 23,138 people hospitalized, a pandemic low and down from 35,991 four weeks ago, a decline of more than one-third. This is a lagging data series from case growth, so the smaller decrease in hospitalizations is consistent with that data as of a couple of weeks ago. Looking at a longer time period, hospitalizations are now at pandemic lows and set to decline further.

Source: https://ourworldindata.org/covid-hospitalizations

Testing news. The testing news is also much better. Overall testing numbers have continued to decline, which is reasonable given the sharp decline in the number of cases. The positive test rate has dropped sharply and is now at the lowest level of the pandemic, at 2.3 percent, down from 4 percent four weeks ago. While we would benefit from more testing, the decline and low level of positive testing rates are supporting evidence that the improvement in the other data is real and could be a leading indicator that the medical risks remain contained.

Source: Johns Hopkins University

Vaccinations. All of these improvements are due to the success of the vaccination rollout. Almost half of the U.S. population has had at least one dose of the vaccine, and 40 percent are fully vaccinated. This has very likely helped contain the number of new infections and has certainly helped keep hospitalizations low. One emerging area of concern is that the vaccination rate is slowing. If that trend continues, it will delay the onset of herd immunity. As of now, it is very possible that we could be at herd immunity by the end of the summer, but that is now at risk.

Source: https://ourworldindata.org/covid-vaccinations

That said, we do seem to have hit containment levels nationally, and herd immunity in many states is now within reach. The bottom line is that infection growth now looks to be controlled and is likely to decline further. While we need to keep an eye on vaccination rates, the trends remain very positive, and we will likely see further improvement over the next month.

The Economy: Improvement in May But Signs of Slowing

The economic data continues to get better overall, although there were signs of slowing. April job growth, in particular, came in much weaker than expected, dropping from 916,000 jobs added in March to 266,000 in April. While this was likely due to a statistical quirk in adjustments, it did raise concerns, although these were alleviated as layoffs continued to decline during the month. Consumer confidence also pulled back a bit. On the business side, confidence also softened, although it is still at high levels, and supply chain concerns raised inflation costs and risks.

Overall, however, the reopening continues and growth remains strong. Many of the problems we do observe are problems of success—the kind of problems we want to have. And, as employment continues to increase and supply chains to heal, we are very likely through the worst of the economic impact of the pandemic.

The Markets: Hold Close to Highs as Recovery Accelerates

Markets saw more new all-time highs last month, supported by the good news on the medical and economic fronts, as well as much better-than-expected corporate earnings reports. Since then, the stock market has bounced around, looking for the next set of good news, but it remains near those highs. With both vaccinations and growth continuing, there is likely support for current valuations and potentially more upside ahead.

Is the Worst Behind Us?

Conditions continued to improve in May, with medical risks continuing to recede and the economy moving forward. The concerns now are much more economic than medical, as we are through the worst of the risks of the pandemic. But even the economic risks are very moderate by recent standards at this point.

Markets continue to do well and may have some more upside ahead. Future gains will depend on further improvement, which while likely is not guaranteed, especially in the short term. Expect more volatility.

In the longer term, the major risks have changed from the severe and immediate (a fourth wave or a collapse in job creation) to the more distant and hypothetical (slowing vaccinations and how quickly we get back to full employment). This shift is good news, as it means the difference between whether we recover and get back to normal, and how quickly. Right now, the good news is that whether we recover seems to be resolved—we are. The better news is that the recovery still looks like it will happen within the next several months. This is a much better place than we were only a couple of months ago, and we continue to move toward the end of the pandemic.


Certain sections of this commentary contain forward-looking statements that are based on our reasonable expectations, estimates, projections, and assumptions. Forward-looking statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Past performance is not indicative of future results.  

Weller Group is located at 6206 Slocum Road, Ontario, NY 14519 and can be reached at 315-524-8000. Securities and Advisory Services offered through Commonwealth Financial Network®, Member FINRA/SIPC, a Registered Investment Adviser. Fixed insurance products and services serviced through Weller Group LLC and KAFL, Inc. are separate and unrelated to Commonwealth.

Authored by Brad McMillan, CFA®, CAIA, MAI, managing principal, chief investment officer, at Commonwealth Financial Network®.

© 2021 Commonwealth Financial Network®